Acadia Pharmaceuticals Inc (ACAD)
Gross Profit Growth
14.69%
Quarterly · Period ending:
ACAD Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported14.69%period ending
Latest reported14.69%period ending
ACAD Quarterly Gross Profit YoY % (-50.05% → 14.69%)
Year-over-year change
High-resolution chart · PNG
ACAD gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 14.6868% | |
| 8.6395% | |
| 8.3957% | |
| 10.988% | |
| 8.9835% | |
| 22.4437% | |
| 11.5642% | |
| 17.4891% | |
| 41.8042% | |
| 56.582% | |
| 58.9758% | |
| 53.2743% | |
| 19.6215% | |
| 3.8012% | |
| 4.5867% | |
| 2.92% | |
| 19.8891% | |
| 10.4612% | |
| 10.7955% | |
| 7.9066% | |
| 5.1477% | |
| 19.7053% | |
| 24.4258% | |
| 28.7874% | |
| 33.7796% | |
| 45.7613% | |
| 68.5279% | |
| 69.8413% | |
| 50.4472% | |
| 28.6363% | |
| 38.4355% | |
| 63.5409% | |
| 90.6377% | |
| 267.5332% | |
| 313.0466% | |
| 719.7822% | |
| 4,127.9173% | |
| 154.2269% | |
| 142.0498% | |
| 121.1236% | |
| 96.3162% | |
| -39.7766% | |
| -26.5454% | |
| -10.3501% | |
| -33.4544% | |
| -39.9811% | |
| -129.9062% | |
| -141.4742% | |
| -106.7407% | |
| -190.0075% | |
| -74.4747% | |
| -660.7375% | |
| -1,212.02% | |
| -991.7778% | |
| -868.8776% | |
| -257.8767% | |
| 30.2174% | |
| 3.4483% | |
| -98.3392% | |
| -74.6197% | |
| -79.9739% | |
| -79.6062% | |
| 1,901.3567% | |
| -5.5031% | |
| 26.2088% | |
| 470.3209% | |
| 444.3077% | |
| 763.4752% | |
| 928.2486% | |
| -53.598% | |
| -79.4694% | |
| -85.5902% | |
| -91.3869% | |
| -58.8776% | |
| -10.7163% | |
| 0.7205% | |
| 9.2504% | |
| -22.7434% | |
| -27.4253% | |
| -47.1077% | |
| -25.1969% | |
| 9.1089% | |
| 125.4938% | |
| 132.3089% | |
| 147.5731% | |
| 151.6723% | |
| -41.2664% | |
| -14.2741% | |
| -55.4771% | |
| -50.0487% |